Drug Profile
Research programme: diabetes therapeutics - ProteoTech
Alternative Names: islet amyloid polypeptide inhibitors - ProteoTech; Type-2 diabetes therapeutics - ProteoTechLatest Information Update: 25 Apr 2023
Price :
$50
*
At a glance
- Originator ProteoTech
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Islet amyloid polypeptide inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 25 Apr 2023 Discontinued - Preclinical for Type 2 diabetes mellitus in USA (unspecified route)
- 28 Sep 2018 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA
- 28 Aug 2014 Preclinical trials in Type-2 diabetes mellitus in USA (unspecified route)